Effect of modulators on the ATPase activity and vanadate nucleotide trapping of human P-glycoprotein

Biochemical Pharmacology

Volumn 56, Issue 6, 1998, Pages 719-727

  Shepard, Robert L ^a   Winter, Mark A ^a   Hsaio, Suzanne C ^a   Pearce, Homer L ^a   Beck, William T ^b   Dantzig, Anne H ^a  

^a ELI LILLY AND COMPANY   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

ATPase; Multidrug resistance; P glycoprotein; Trimethoxybenzoylyohimbine; Verapamil stimulation

Indexed keywords

ADENOSINE TRIPHOSPHATASE; AMIODARONE; CYCLOSPORIN A; GLYCOPROTEIN P; NICARDIPINE; NUCLEOTIDE; PACLITAXEL; TRIFLUOPERAZINE; VANADIUM; VERAPAMIL; VINBLASTINE; VINDOLINE; YOHIMBINE DERIVATIVE;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; LEUKEMIA CELL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL;

ADENOSINE TRIPHOSPHATASES; ADENOSINE TRIPHOSPHATE; ANTINEOPLASTIC AGENTS, PHYTOGENIC; AZIDES; BINDING SITES; CALCIUM CHANNEL BLOCKERS; CELL MEMBRANE; DRUG INTERACTIONS; DRUG RESISTANCE, MULTIPLE; HUMANS; HYDROLYSIS; LEUKEMIA, LYMPHOCYTIC; P-GLYCOPROTEIN; PHOSPHORUS RADIOISOTOPES; PROTEIN CONFORMATION; STIMULATION, CHEMICAL; TUMOR CELLS, CULTURED; VANADATES; VERAPAMIL; VINBLASTINE; YOHIMBINE;

EID: 0032530441     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(98)00212-3     Document Type: Article

References (43)

1. van der Bliek A.M., Borst P. Multidrug resistance. Adv Cancer Res. 52:1989;165-202.
2. Roninson I.B. Molecular and Cellular Biology of Multidrug Resistance in Tumor Cells. 1990;Plenum Publishing, New York.
3. Gros P., Neriah Y.B., Croop J.M., Housman D.E. Isolation and expression of a complementary DNA that confers multidrug resistance. Nature. 323:1986;728-731.
4. Ueda K., Cardarelli C., Gottesman M.M., Pastan I. Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine. Proc Natl Acad Sci USA. 84:1987;3004-3008.
5. Endicott J.A., Ling V. The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu Rev Biochem. 58:1989;137-171.
6. 2+-dependent binding of vincristine to the plasma membrane of multidrug-resistant K562 cells. J Biol Chem. 263:1988;11887-11891.
7. Horio M., Gottesman M.M., Pastan I. ATP-dependent transport of vinblastine in vesicles from human multidrug-resistant cells. Proc Natl Acad Sci USA. 85:1988;3580-3584.
8. Sarkadi B., Price E.M., Boucher R.C., Germann U.A., Scarborough G.A. Expression of the human multidrug resistance cDNA in insect cells generates a high activity drug-stimulated membrane ATPase. J Biol Chem. 267:1992;4854-4858.
9. Ambudkar S.V., Lelong I.H., Zhang J., Cardarelli C.O., Gottesman M.M., Pastan I. Partial purification and reconstitution of the human multidrug-resistance pump Characterization of the drug-stimulatable ATP hydrolysis . Proc Natl Acad Sci USA. 89:1992;8472-8476.
10. Hamada H., Tsuruo T. Purification of the 170- to 180-kilodalton membrane glycoprotein associated with multidrug resistance. 170- to 180-Kilodalton membrane glycoprotein is an ATPase. J Biol Chem. 263:1988;1454-1458.
11. r 170,000 to 180,000 membrane glycoprotein (P-glycoprotein) associated with multidrug resistance in K562/ADM cells. Cancer Res. 48:1988;4926-4932.
12. Sharom F.J., Yu S., Doige C.A. Functional reconstitution of drug transport and ATPase activity in proteoliposomes containing partially purified P-glycoprotein. J Biol Chem. 268:1993;24197-24202.
13. Shapiro A.B., Ling V. ATPase activity of purified and reconstituted P-glycoprotein from Chinese hamster ovary cells. J Biol Chem. 269:1994;3745-3754.
14. Ford J.M., Hait W.N. Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacol Rev. 42:1990;155-199.
15. Beck W.T. Modulators of P-glycoprotein-associated multidrug resistance. Cancer Treat Res. 57:1991;151-170.
16. Arceci R.J., Stieglitz K., Bierer B.E. Immunosuppressants FK506 and rapamycin function as reversal agents of the multidrug resistance phenotype. Blood. 80:1992;1528-1536.
17. Mizuno K., Furuhashi Y., Misawa T., Iwata M., Kawai M., Kikkawa F., Kano T., Tomoda Y. Modulation of multidrug resistance by immunosuppressive agents Cyclosporin analogues, FK506, and mizoribine . Anticancer Res. 12:1992;21-26.
18. Dantzig A.H., Shepard R.L., Cao J., Law K.L., Ehlhardt W.J., Baughman T.M., Bumol T., Starling J.J. Reversal of P-glycoprotein-mediated multidrug resistance by a potent cyclopropyldibenzosuberane modulator, LY335979. Cancer Res. 56:1996;4171-4179.
19. Pearce H.L., Safa A.R., Bach N.J., Winter M.A., Cirtain M.C., Beck W.T. Essential features of the P-glycoprotein pharmacophore as defined by a series of reserpine analogs that modulate multidrug resistance. Proc Natl Acad Sci USA. 86:1989;5128-5132.
20. Beck W.T., Mueller M.J., Tanzer L.R. Altered surface membrane glycoproteins in Vinca alkaloid-resistant human leukemic lymphoblasts. Cancer Res. 39:1979;2070-2076.
21. + gradient-stimulated uptake. J Biol Chem. 252:1977;1990-1997.
22. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Garter F.H., Provenzano M.D., Fujimoto E.K., Goeke N.M., Olson B.J., Klenk D.C. Measurement of protein using bicinchoninic acid. Anal Biochem. 150:1985;76-85.
23. Fiske C.H., Subbarow Y. The colorimetric determination of phosphorous. J Biol Chem. 66:1925;375-400.
24. Urbatsch I.L., Sankaran B., Weber J., Senior A.E. P-Glycoprotein is stably inhibited by vanadate-induced trapping of nucleotide at a single catalytic site. J Biol Chem. 270:1995;19383-19390.
25. Pearce H.L., Winter M.A., Beck W.T. Structural characteristics of compounds that modulate P-glycoprotein-associated multidrug resistance. Adv Enzyme Regul. 30:1989;357-373.
26. Doige C.A., Yu X., Sharom F.J. The effects of lipids and detergents on ATPase-active P-glycoprotein. Biochim Biophys Acta. 1146:1993;65-72.
27. Urbatsch I.L., Senior A.E. Effects of lipids on ATPase activity of purified Chinese hamster P-glycoprotein. Arch Biochem Biophys. 316:1995;135-140.
28. Al-Shawi M.K., Senior A.E. Characterization of the adenosine triphosphatase activity of Chinese hamster P-glycoprotein. J Biol Chem. 268:1993;4197-4206.
29. Garrigos M., Mir L.M., Orlowski S. Competitive and non-competitive inhibition of the multidrug-resistancs-associated P-glycoprotein ATPase-Further experimental evidence for a multisite model. Eur J Biochem. 244:1997;664-673.
30. Rao U.S., Scarborough G.A. Direct demonstration of high affinity interactions of immunosuppressant drugs with the drug binding site of the human P-glycoprotein. Mol Pharmacol. 45:1994;773-776.
31. Borgnia M.J., Eytan G.D., Assaraf Y.G. Competition of hydrophobic peptides, cytotoxic drugs, and chemosensitizers on a common P-glycoprotein pharmacophore as revealed by its ATPase activity. J Biol Chem. 271:1996;3163-3171.
32. Litman T., Zeuthen T., Skovsgaard T., Stein W.D. Structure-activity relationships of P-glycoprotein interacting drugs Kinetic characterization of their effects on ATPase activity . Biochim Biophys Acta. 1361:1997;159-168.
33. Watanabe T., Kokubu N., Charnick S.E., Naito M., Tsuruo T., Cohen D. Interaction of cyclosporin derivatives with the ATPase activity of human P-glycoprotein. Br J Pharmacol. 122:1997;241-248.
34. Cornwell M.M., Gottesman M.M., Pastan I.H. Increased vinblastine binding to membrane vesicles from multidrug-resistant KB cells. J Biol Chem. 261:1986;7921-7928.
35. Zamora J.M., Pearce H.L., Beck W.T. Physical-chemical properties shared by compounds that modulate multidrug resistance in human leukemic cells. Mol Pharmacol. 33:1988;454-462.
36. Rao U.S. Mutation of glycine 185 to valine alters the ATPase function of the human P-glycoprotein expressed in Sf9 cells. J Biol Chem. 270:1995;6686-6690.
37. Ferry D.R., Russell M.A., Cullen M.H. P-Glycoprotein possesses a 1,4-dihydropyridine-selective drug acceptor site which is allosterically coupled to a vinca-alkaloid-selective binding site. Biochem Biophys Res Commun. 188:1992;440-445.
38. Orlowski S., Mir L.M., Belehradek J. Jr, Garrigos M. Effects of steroids and verapamil on P-glycoprotein ATPase activity Progesterone, desoxycorticosterone, corticosterone and verapamil are mutually non-exclusive modulators . Biochem J. 317:1996;515-522.
39. Loo T.W., Clarke D.M. Drug-stimulated ATPase activity of human P-glycoprotein requires movement between transmembrane segments 6 and 12. J Biol Chem. 272:1997;20986-20989.
40. Gottesman M.M., Pastan I. The multidrug transporter, a double-edged sword. J Biol Chem. 263:1988;12163-12166.
41. Safa A.R., Stern R.K., Choi K., Agresti M., Tamai I., Mehta N.D., Roninson I.B. Molecular basis of preferential resistance to colchicine in multidrug-resistant human cells conferred by Gly-185->Val-185 substitution in P-glycoprotein. Proc Natl Acad Sci USA. 87:1987;7225-7229.
42. Bruggemann E.P., Currier S.J., Gottesman M.M., Pastan I. Characterization of the azidopine and vinblastine binding site of P-glycoprotein. J Biol Chem. 267:1992;21020-21026.
43. Loo T.W., Clarke D.M. Reconstitution of drug-stimulated ATPase activity following co-expression of each half of human P-glycoprotein as separate polypeptides. J Biol Chem. 269:1994;7750-7755.